WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 3Y Ago
-39x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -100.00% |
| Q3 2025 | 25.93% |
| Q2 2025 | -77.31% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | -100.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | -100.00% |
| Q1 2023 | -35.00% |
| Q4 2022 | 2.56% |
| Q3 2022 | 8.33% |
| Q2 2022 | 38.46% |
| Q1 2022 | -40.91% |
| Q4 2021 | 0.00% |
| Q3 2021 | -100.00% |
| Q2 2021 | -29.17% |
| Q1 2021 | 14.29% |
| Q4 2020 | 0.00% |
| Q3 2020 | -100.00% |
| Q2 2020 | -11.81% |
| Q1 2020 | -4.24% |
| Q4 2019 | -25.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | -12.87% |
| Q1 2019 | -12.84% |
| Q4 2018 | -3.66% |
| Q3 2018 | 34.43% |
| Q2 2018 | -20.98% |
| Q1 2018 | 26.56% |
| Q4 2017 | -20.78% |
| Q3 2017 | 6.94% |
| Q2 2017 | -20.12% |
| Q1 2017 | -9.87% |
| Q4 2016 | 1.01% |
| Q3 2016 | 0.00% |
| Q2 2016 | -100.00% |
| Q1 2016 | 0.00% |